| Literature DB >> 34263302 |
Barbara Del Frari1, Cornelia Blank2, Stephan Sigl1, Anton H Schwabegger1, Eva Gassner3, David Morawetz2,4, Wolfgang Schobersberger2,4.
Abstract
OBJECTIVES: Since the introduction of the minimally invasive technique for repair of pectus excavatum (MIRPE), increasing numbers of patients are presenting for surgery. However, controversy remains regarding cardiopulmonary outcomes of surgical repair. Therefore, the aim of our prospective study was to investigate cardiopulmonary function, at rest and during exercise before surgery, first after MIRPE and then after pectus bar removal.Entities:
Keywords: Cardiopulmonary function; Echocardiography; Exercise; Pectus excavatum; Spiroergometry; Thoracoplasty
Mesh:
Year: 2021 PMID: 34263302 PMCID: PMC8715845 DOI: 10.1093/ejcts/ezab296
Source DB: PubMed Journal: Eur J Cardiothorac Surg ISSN: 1010-7940 Impact factor: 4.191
Figure 1:Clinical presentation of a male patient (aged 16 years) who had undergone Minor Open Videoendoscopically Assisted Repair of Pectus Excavatum surgery and pectus bar removal: presurgery (left picture) and at 8 months post-surgery (right picture).
Reasons for patient exclusion from this study
| Number of patients excluded (males/females) | Reason |
|---|---|
| 4 (2 males/2 females) | Failed to appear for first study visit after giving consent to be included |
| 5 (4 males/1 female) | Had no objective pathology at their preoperative screening and thus no desire for surgery |
| 7 (6 males/1 female) | Had no objective indications for surgery even though correction of deformity was desired |
| 6 (6 males) | Had objective indications for surgical correction other than MOVARPE, e.g. lipofilling, custom-made silicone implant |
| 4 (4 males) | Could not be reached for final follow-up after MOVARPE |
| 2 (1 male/1 female) | Had cardiological findings (long QT syndrome, |
MOVARPE: Minor Open Videoendoscopically Assisted Repair of Pectus Excavatum; PFT: pulmonary function test.
Characteristics of the patients (n = 19) at the pre- and post-surgery 1 and 2 cardiopulmonary testing time points and at the time of surgery
| Variables | Pre (M ± SD) | MOVARPE (M ± SD) | Post 1 (M ± SD) | Post 2 (M ± SD) |
|---|---|---|---|---|
| Age (years) | 15.6 ± 1.6 | 16.6 ± 1.7 | 16.7 ± 1.7 | 18.6 ± 1.9 |
| Body weight (kg) | 56.3 ± 7.5 | 56.5 ± 7.2 | 59.9 ± 8.5 | 62.8 ± 8.6 |
| Body height (cm) | 176.3 ± 7.5 | 176.6 ± 7.2 | 178.1 ± 7.0 | 179.6 ± 7.3 |
M ± SD: mean ± standard deviation; MOVARPE: Minor Open Videoendoscopically Assisted Repair of Pectus Excavatum; Post 1: 7.6 ± 2.2 months after surgery; Post 2: 5.7 ± 7.9 months after pectus bar removal; Pre: baseline (before surgical intervention).
Data from the pre- and post-surgery 1 and 2 pulmonary function tests (n = 19)
| Variables | Pre (M ± SD) | Post 1 (M ± SD) | Post 2 (M ± SD) |
|
|---|---|---|---|---|
| FVC (l) | 3.8 ± 0.9 | 3.8 ± 0.7 | 4.3 ± 0.7*,** | <0.001 (0.44) |
| FVC (%pred) | 78.7 ± 13.4 | 75.4 ± 9.8 | 80.9 ± 9.9 | 0.076 (0.32) |
| FEV1 (l) | 3.3 ± 0.9 | 3.5 ± 0.7 | 3.7 ± 0.8 | 0.001 (0.31) |
| FEV1 (%pred) | 79.3 ± 16.5 | 80.1 ± 11.7 | 81.7 ± 15.2 | 0.63 (0.03) |
| FEV1/FVC (%) | 85.8 ± 9.0 | 90.8 ± 7.4 | 85.7 ± 11.6 | <0.001 (0.31) |
| FEV1/FVC (%pred) | 99.8 ± 10.6 | 105.6 ± 8.8 | 99.6 ± 13.4 | 0.001 (0.31) |
P-values <0.05 were considered statistically significant.
FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; M ± SD: mean ± standard deviation; % pred: percentage of predictive value according to Quanjer et al. [22]; Post 1: 7.6 ± 2.2 months after surgery; Post 2: 5.7 ± 7.9 months after pectus bar removal; Pre: baseline (before surgical intervention);.
Friedman test.
Statistically significant compared to ‘Pre’.
Statistically significant compared to ‘Post 1’.
Cycle spiroergometry results obtained in the sitting and supine positions (n = 19)
| Variables | Sitting position | Supine position | ||||||
|---|---|---|---|---|---|---|---|---|
| Pre, M ± SD (range) | Post 1, M ± SD (range) | Post 2, M ± SD (range) |
| Pre, M ± SD (range) | Post, M ± SD (range) | Post 2, M ± SD (range) |
| |
| Mean power 2 mmol (W/kg) | 1.5 ± 0.4 (0.5; 2.3) | 1.3 ± 0.3 (0.8; 2.1) | 1.3 ± 0.3 (0.9; 1.8) | 0.25 (0.12) | 1.4 ± 0.3 (0.6; 1.9) | 1.4 ± 0.3 (0.9; 1.9) | 1.4 ± 0.3 (0.9; 2.0) | 0.95 (0.003) |
| Mean power4 mmol (W/kg)a,b | 2.2 ± 0.4 (1.4; 2.8) | 2.1 ± 0.3 (1.4; 2.8) | 2.0 ± 0.3* (1.4; 2.4) | 0.01 (0.21) | 2.1 ± 0.3 (1.6; 2.5) | 1.9 ± 0.2 (1.5; 2.3) | 2.0 ± 0.5 (1.6; 4.0) | 0.33 (0.05) |
| Peak power (W/kg) | 3.1 ± 0.5 (2.0; 4.1) | 3.0 ± 0.4 (2.0; 3.7) | 3.0 ± 0.3 (2.4; 3.5) | 0.26 (0.07) | 2.5 ± 0.5 (1.6; 3.6) | 2.3 ± 0.5* (1.4; 3.4) | 2.4 ± 0.5 (1.7; 3.3) | 0.04 (0.11) |
| Peak power (W) | 173.9 ± 37.2 (100.0; 238.0) | 179.2 ± 36.2 (104.0; 250.0) | 187.6 ± 33.9* (132.0; 275.0) | 0.03 (0.18) | 139.8 ± 34.3 (87.0; 220.0) | 141.5 ± 34.7 (81.0; 225.0) | 153.3 ± 30.2** (92.0; 200.0) | 0.005 (0.25) |
| VO2 peak (ml/kg/min) | 41.0 ± 6.2 (26.4; 52.5) | 40.9 ± 6.2 (27.6; 54.3) | 40.4 ± 4.0 (32.7; 48.9) | 0.86 (0.01) | 36.2 ± 6.4 (26.5; 49.3) | 34.5 ± 6.1 (22.6; 47.3) | 34.4 ± 5.6 (24.3; 45.4) | 0.6 (0.1) |
| HRpeak (bpm) | 192.5 ± 7.81 (171.0; 206.0) | 192.2 ± 8.5 (164.0; 203.0) | 188.5 ± 9.8 (173.0; 206.0) | 0.06 (0.14) | 169.1 ± 18.6 (129.0; 193.0) | 165.3 ± 19.6 (129.0; 196.0) | 169.4 ± 18.9 (141; 196) | 0.77 (0.05) |
| Lactatepeak (mmol/l) | 8.7 ± 2.5 (4.3; 13.7) | 9.6 ± 2.7* (4.0; 13.9) | 9.8 ± 2.1 (6.3; 13.5) | 0.03 (0.17) | 6.6 ± 3.0 (2.2; 12.5) | 6.7 ± 2.9 (2.3; 12.4) | 7.4 ± 2.8 (3.8; 13.1) | 0.24 (0.08) |
P-values <0.05 were considered statistically significant;
HRpeak: heart rate (peak); M ± SD: mean ± standard deviation; Pre: baseline (before surgical intervention); Post 1: 7.6 ± 2.2 months after surgery; Post 2: 5.7 ± 7.9 months after pectus bar removal; VO2: oxygen consumption.
Friedman test sitting position.
n = 14.
tatistically significant compared to ‘Pre’.
Statistically significant compared to ‘Post 1’.
Figure 2:Three-dimensional volume-rendered computed tomography of the thorax of the same patient shown in Fig. 1: pre-surgery (left) and at 6 months after pectus bar removal (right).